Sign in
Sign in
Recover your password.
A password will be e-mailed to you.
WHO publishes first-ever malaria vaccine recommendation in position paper
The paper complements the recent addition of the recommendation to the WHO guidelines for malaria
Pharma industry reports 58 deals worth $6.3 billion in February, says GlobalData
The industry reported 116 VC deals worth $3.2 billion in February 2022, compared to the last 12-month average (February 2021 to…
Civica aims to launch low-cost insulin in US by 2024
Civica, launched in 2018 to make generic drugs, said it would produce three copycat versions of insulin
We envision being a leading global dermatology company in India in next 10 years
Menarini India has a presence in the dermatology and primary care segments in the Indian market with its own brands. Recently, the…
Decision on mixing and matching of booster dose of COVID vaccines will be based on science:…
Addressing a press conference, V K Paul, member (health), NITI Aayog, said studies are going on regarding the mixing and matching…
Pfizer to provide 10 million courses of COVID-19 pill to developing countries: Global Fund
The Fund's head of strategy for policy, Harley Feldbaum, said Pfizer had committed to at least that many doses, and could increase…
Roche teams up with research institutions for new Alzheimer’s trial
The trial aims to evaluate the potential of gantenerumab to slow disease progression in people with the earliest biological signs…
WuXi STA passes first EMA drug product pre-approval inspection for Wuxi city site
The PAI focussed on the drug product manufacturing of an innovative drug for one of WuXi STA’s partners
Study finds Neem tree-based drugs may help fight against COVID
The study, led by a team from the Indian Institute of Science Education and Research, Kolkata, shows that components of Neem bark…
US FDA extends review period for expanded use of Abbvie’s psoriasis drug
The US Food and Drug Administration (FDA) was reviewing the application for the use of Skyrizi in patients aged 16 years or older…